Home › Lung Cancer › Wisconsin › Stevens Point
Lung Cancer clinical trials in Stevens Point, WI
10 studies for Lung Cancer are looking for participants at sites in and around Stevens Point (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RecruitingPhase 3
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecruitingPhase 3
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecruitingPhase 3
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Aspirus Cancer Care - Stevens Point, Stevens Point
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
- Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids · 15 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RecruitingObservational study
- Marshfield Medical Center-River Region at Stevens Point, Stevens Point
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Arlington, VA40 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Stevens Point
- Non-Small Cell Lung Cancer8 studies
- Prostate Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Acute Myeloid Leukemia6 studies
- Breast Cancer5 studies
- Colorectal Cancer5 studies
- Hypopharyngeal Cancer5 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Melanoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Pancreatic Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.